Drug intelligence / Profile preview

Wuji Tiaotang Oral Liquid

Development stage: Unknown
Lead developer: Wuhan Juneng Jinshi Pharmaceutical
Administration: Oral

Overview

Wuji Tiaotang Oral Liquid (乌鸡调糖口服液) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Wuhan Juneng Jinshi Pharmaceutical. It is approved in China for the treatment of "Xiaoke" (diabetes-related symptoms) associated with Qi and Yin deficiency. The formulation typically contains ingredients such as black-boned chicken (Gallus gallus domesticus), ginseng, and astragalus, which are traditionally used to nourish Yin, clear heat, and benefit Qi. It is administered orally as a syrup or oral liquid to help regulate blood sugar and alleviate symptoms like excessive thirst, hunger, and fatigue.

Brand names: Wuji Tiaotang Oral LiquidWuji Blood Sugar Syrup
Other names: 乌鸡调糖口服液Wuji Tiaotang Koufuye

Beyond the preview

Go deeper on Wuji Tiaotang Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuji Tiaotang Oral Liquid.

Explore the full profile